Home/MAIA Biotechnology/Sergei M. Gryaznov

SM

Sergei M. Gryaznov

Chief Scientific Officer

MAIA Biotechnology

Therapeutic Areas

MAIA Biotechnology Pipeline

Drug	Indication	Phase
Ateganosine (THIO)	Cancer	Phase 2
Second-generation telomere targeting agents	Cancer	Pre-clinical/Research

Leadership Team at MAIA Biotechnology

Chief Executive Officer and Chairman

Jeffrey C. Himmelreich

Head of Finance

View full MAIA Biotechnology profile